Literature DB >> 20842687

Severe dystonic encephalopathy without hyperphenylalaninemia associated with an 18-bp deletion within the proximal GCH1 promoter.

Marek Bodzioch1, Katarzyna Lapicka-Bodzioch, Monika Rudzinska, Jacek J Pietrzyk, Miroslaw Bik-Multanowski, Andrzej Szczudlik.   

Abstract

In a recent GCH1 mutation screen, an 18-bp deletion was identified within the proximal promoter in two patients with early-onset Parkinson's disease. The mutation removes cAMP response element critical for adequate GTP cyclohydrolase I activity in selected cell types, including dopaminergic neurons, but its biological significance was unclear as it was also detected in one control individual. We present an 11-year-old boy with infantile-onset severe dystonic encephalopathy without hyperphenylalaninemia whom we found compound heterozygous for the same promoter GCH1 deletion and another common missense mutation associated with classical dopa-responsive dystonia. Extensive diagnostic work up excluded other causes of dystonia, and comprehensive mutation scan did not reveal any additional GCH1 sequence variations, supporting the association between the promoter deletion and disease phenotype.
Copyright © 2010 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20842687     DOI: 10.1002/mds.23364

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  2 in total

1.  Case Report: Severe Hypotonia Without Hyperphenylalaninemia Caused by a Homozygous GCH1 Variant: A Case Report and Literature Review.

Authors:  Yun Chen; Kaiyu Liu; Zailan Yang; Yaozhou Wang; Hao Zhou
Journal:  Front Genet       Date:  2022-07-13       Impact factor: 4.772

2.  GTP cyclohydrolase I and tyrosine hydroxylase gene mutations in familial and sporadic dopa-responsive dystonia patients.

Authors:  Chunyou Cai; Wentao Shi; Zheng Zeng; Meiyun Zhang; Chao Ling; Lei Chen; Chunquan Cai; Benshu Zhang; Wei-Dong Li
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.